| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 National Institute of Neuroscience, NCNP, 4-1-1 Ogawahigashi, Kodaira, Tokyo 1871, Japan
2 National Institute of Health, 4-7-1 Gakuen, Musashimurayama, Tokyo 190-122, Japan
The receptor proteins, MHVR1 (Bgp C or splice variant of mmCGM1 containing two ectodomains) and MHVR2 (mmCGM2) have been reported to be functional receptors for MHV, although there was a significant difference in their virus-binding activity as determined by virus overlay protein blot assay (VOPBA). To compare the receptor function of these proteins, their virus-binding capacities were tested by using soluble forms of the proteins which lacked the transmembrane and intracytoplasmic domains. To estimate the amounts of these proteins expressed, an epitope of influenza HA protein, for which specific monoclonal antibody was available, was used as a tag. Recombinant soluble MHVR1 and MHVR2, expressed in RK 13 cells using recombinant vaccinia virus were secreted into the culture fluids of infected cells expressing these proteins. The inhibitory effect on virus infectivity of MHVR1 was shown to be about 500-fold higher than that of MHVR2. A similar disparity was observed in virus binding by VOPBA. These two proteins worked as functional receptors when they were expressed on resistant BHK-21 cells. However, the efficiency of MHV infection in BHK-21 cells expressing MHVR1 was about 30-fold higher, as compared with those expressing MHVR2. These data show that the receptor function of MHVR1 was significantly higher than that of MHVR2 and suggests that the difference in susceptibility between SJL and BALB/c mice might be due to the specific receptor protein expressed in those animals.
Received 11 January 1996;
accepted 23 February 1996.
This article has been cited by other articles:
|
|
 |
|
  M. H. Verheije, T. Wurdinger, V. W. van Beusechem, C. A. M. de Haan, W. R. Gerritsen, and P. J. M. Rottier Redirecting Coronavirus to a Nonnative Receptor through a Virus-Encoded Targeting Adapter J. Virol., February 1, 2006; 80(3): 1250 - 1260. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. S. Miura, K. Nakagaki, and F. Taguchi N-Terminal Domain of the Murine Coronavirus Receptor CEACAM1 Is Responsible for Fusogenic Activation and Conformational Changes of the Spike Protein J. Virol., January 1, 2004; 78(1): 216 - 223. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Ontiveros, T. S. Kim, T. M. Gallagher, and S. Perlman Enhanced Virulence Mediated by the Murine Coronavirus, Mouse Hepatitis Virus Strain JHM, Is Associated with a Glycine at Residue 310 of the Spike Glycoprotein J. Virol., October 1, 2003; 77(19): 10260 - 10269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. D. Zelus, J. H. Schickli, D. M. Blau, S. R. Weiss, and K. V. Holmes Conformational Changes in the Spike Glycoprotein of Murine Coronavirus Are Induced at 37{degrees}C either by Soluble Murine CEACAM1 Receptors or by pH 8 J. Virol., January 15, 2003; 77(2): 830 - 840. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Matsuyama and F. Taguchi Receptor-Induced Conformational Changes of Murine Coronavirus Spike Protein J. Virol., December 1, 2002; 76(23): 11819 - 11826. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Taguchi and S. Matsuyama Soluble Receptor Potentiates Receptor-Independent Infection by Murine Coronavirus J. Virol., February 1, 2002; 76(3): 950 - 958. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Taguchi and Y. K. Shimazaki Functional analysis of an epitope in the S2 subunit of the murine coronavirus spike protein: involvement in fusion activity J. Gen. Virol., December 1, 2000; 81(12): 2867 - 2871. [Abstract] [Full Text]
|
|
|
|
|
|
R. S. Baric, E. Sullivan, L. Hensley, B. Yount, and W. Chen Persistent Infection Promotes Cross-Species Transmissibility of Mouse Hepatitis Virus J. Virol., January 1, 1999; 73(1): 638 - 649. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. D. Zelus, D. R. Wessner, R. K. Williams, M. N. Pensiero, F. T. Phibbs, M. deSouza, G. S. Dveksler, and K. V. Holmes Purified, Soluble Recombinant Mouse Hepatitis Virus Receptor, Bgp1b, and Bgp2 Murine Coronavirus Receptors Differ in Mouse Hepatitis Virus Binding and Neutralizing Activities J. Virol., September 1, 1998; 72(9): 7237 - 7244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Wessner, P. C. Shick, J.-H. Lu, C. B. Cardellichio, S. E. Gagneten, N. Beauchemin, K. V. Holmes, and G. S. Dveksler Mutational Analysis of the Virus and Monoclonal Antibody Binding Sites in MHVR, the Cellular Receptor of the Murine Coronavirus Mouse Hepatitis Virus Strain A59 J. Virol., March 1, 1998; 72(3): 1941 - 1948. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
